Nektar Therapeutics (NKTR) Nasdaq Global Select
CloseJanuary 23, 2019

News: updated – 23-Jan 06:38

Jefferies bearish on biotechs, sees 6% near-term downside23-Jan 02:05(SeekingAlpha)

Jefferies healthcare strategist Jared Holtz is a short-term biotech bear saying that profit-taking "makes sense" through this earnings season considering the sector’s market-leading performance so far this year. He thinks the SPDR S&P Biotech ETF ( XBI -1.3% ) could drop to $75 ( -6% )…